1. Reduced-Intensity Conditioning Allogeneic Blood Stem Cell Transplantation with Fludarabine and Oral Busulfan with or without Pharmacokinetically Targeted Busulfan Dosing in Patients with Myeloid Leukemia Ineligible for Conventional Conditioning 
Rodrigo Martino, José A. Pérez-Simón, Estela Moreno, José M. Queraltó, Dolores Caballero, Marivi Mateos, Anna Sureda, Consuelo Cañizo, Salut Brunet, Javier Briones, Lourdes Vazquez, Ana Clopés, Jesús F. San Miguel, Jorge Sierra 
Biology of Blood and Marrow Transplantation 
Volume 11, Issue 6, Pages (June 2005)
DOI: /j.bbmt
Copyright © 2005 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Days after transplantation on which peripheral blood (PB) T cells and granulocytes were 100% of donor origin (complete donor chimerism; CDC) in the 54 evaluable patients. CDC in PB was reached earlier in granulocytes (——) than in T cells (–––), without differences between transplantation groups.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2005 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Incidence of nonrelapse mortality (NRM) according to transplantation group. The 2-year NRM was 12% (95% confidence interval, 3.4%-21.1%) in the targeted group (–·–·) and 10% (95% confidence interval, 9.3%-32%) in the nontargeted group.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2005 American Society for Blood and Marrow Transplantation Terms and Conditions